含V-Set域T-細(xì)胞激活抑制因子1(VTCN1)多克隆抗體
Polyclonal Antibody to V-Set Domain Containing T-Cell Activation Inhibitor 1 (VTCN1)
B7-H4; B7H4; B7S1; B7X; B7h.5; VCTN1; T-cell costimulatory molecule B7x; Immune costimulatory protein B7-H4
- 編號(hào)PAK032Hu01
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價(jià)-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 RPK032Hu01-含V-Set域T-細(xì)胞激活抑制因子1(VTCN1)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度0.44mg/ml
- 且適物種Mus musculus (Mouse，小鼠), Rattus norvegicus (Rat，大鼠), Sus scrofa; Porcine (Pig，豬)
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù)，請(qǐng)參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價(jià)格 ¥ 630 ¥ 1470 ¥ 2100 ¥ 5250 ¥ 21000
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
DAB staining on IHC-P; Samples: Human Spleen Tissue; Primary Ab: 20μg/ml Rabbit Anti-Human VTCN1 Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
-
DAB staining on IHC-P;
Samples: Human Pancreas Tissue;
Primary Ab: 20μg/ml Rabbit Anti-Human VTCN1 Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
Figure. Western Blot; Sample: Recombinant VTCN1, Human.
-
Western Blot; Sample: Human Serum;
Primary Ab: 1μg/ml Rabbit Anti-Human VTCN1 Antibody
Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19) -
Western Blot; Sample: Human Liver lysate;
Primary Ab: 2μg/ml Rabbit Anti-Human VTCN1 Antibody
Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19) -
Western Blot; Sample: Human A549 cell lysate;
Primary Ab: 2μg/ml Rabbit Anti-Human VTCN1 Antibody
Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對(duì)VTCN1的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別VTCN1。
用法
Western blotting: 0.01-2μg/mL
Immunohistochemistry: 5-20μg/mL
Immunocytochemistry: 5-20μg/mL
Optimal working dilutions must be determined by end user.
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽性對(duì)照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長(zhǎng)臂生物素標(biāo)記試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPK032Hu02 | 含V-Set域T-細(xì)胞激活抑制因子1(VTCN1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPK032Hu03 | 含V-Set域T-細(xì)胞激活抑制因子1(VTCN1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPK032Hu01 | 含V-Set域T-細(xì)胞激活抑制因子1(VTCN1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAK032Hu01 | 含V-Set域T-細(xì)胞激活抑制因子1(VTCN1)多克隆抗體 | WB; IHC; ICC; IP. |
| PAK032Hu03 | 含V-Set域T-細(xì)胞激活抑制因子1(VTCN1)多克隆抗體 | WB; IHC; ICC; IP. |
| PAK032Hu02 | 含V-Set域T-細(xì)胞激活抑制因子1(VTCN1)多克隆抗體 | WB; IHC; ICC; IP. |
| LAK032Hu71 | 含V-Set域T-細(xì)胞激活抑制因子1(VTCN1)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| LAK032Hu81 | 含V-Set域T-細(xì)胞激活抑制因子1(VTCN1)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| MAK032Hu21 | 含V-Set域T-細(xì)胞激活抑制因子1(VTCN1)單克隆抗體 | WB; IHC; ICC; IP. |
| SEK032Hu | 含V-Set域T-細(xì)胞激活抑制因子1(VTCN1)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMK032Hu | 含V-Set域T-細(xì)胞激活抑制因子1(VTCN1)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| International Journal of Clinical Oncology | Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance [Pubmed:24804867] |
| Iranian?Journal of Immunology | Increased Serum Levels of Soluble B7-H4 in Patients with Systemic Lupus Erythematosus. [Pubmed: 30864554] |
